Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

NCT01852708 · clinicaltrials.gov ↗

COMPLETED

Status

1059

Enrollment

INDUSTRY

Sponsor class

Conditions

Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Abnormalities
Microdeletion Syndromes

Sponsor

Natera, Inc.